IGC-AD1

N/A

Report date: 2024/06/11 17:35:22
NME

Base Information

Drug NameIGC-AD1
Drug Alias NameMelatonin/tetrahydrocannabinol (India Globalization Capital)IGC-AD1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor agonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsPsychomotor AgitationAlzheimer DiseaseDementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPuerto Rico +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of South Florida
China Registration ClassN/A

Develop Information

Active CompaniesIGC Pharma Inc
Inactive CompaniesN/A
Active IndicationsPsychomotor AgitationAlzheimer DiseaseDementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A